Low-risk prostate cancer can and should often be managed with active surveillance and selective delayed intervention

Nature Clinical Practice Urology

Volumn 5, Issue 1, 2008, Pages 2-3

  Klotz, Laurence ^a  

^a UNIVERSITY OF TORONTO   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

PROSTATE SPECIFIC ANTIGEN;

CANCER SCREENING; CANCER SURVIVAL; CLINICAL EFFECTIVENESS; DIGITAL RECTAL EXAMINATION; DISEASE COURSE; DISEASE SURVEILLANCE; GLEASON SCORE; HUMAN; LIFE EXPECTANCY; OVERALL SURVIVAL; PATIENT MONITORING; PRIORITY JOURNAL; PROGNOSIS; PROSTATE CANCER; PROSTATECTOMY; PSYCHOLOGICAL WELL BEING; REVIEW; RISK ASSESSMENT; THERAPY DELAY; TRANSRECTAL ULTRASONOGRAPHY; TUMOR BIOPSY;

DISEASE PROGRESSION; HUMANS; MALE; POPULATION SURVEILLANCE; PROSTATE-SPECIFIC ANTIGEN; PROSTATIC NEOPLASMS; RISK FACTORS; TIME FACTORS;

EID: 38049117637     PISSN: 17434270     EISSN: 17434289     Source Type: Journal    
DOI: 10.1038/ncpuro0993     Document Type: Review

References (9)

1. Jemal A et al. (2004) Cancer statistics, 2004. CA Cancer J Clin 54: 8-29
2. Welch HG et al. (2005) Prostate-specific antigen levels in the United States: Implications of various definitions for abnormal. J Natl Cancer Inst 97: 1132-1137
3. Epstein JI et al. (1998) Nonpalpable stage T1c prostate cancer: prediction of insignificant disease using free/total prostate specific antigen levels and needle biopsy findings. J Urol 160: 2407-2411
4. Klotz L (2005) Active surveillance for prostate cancer: For whom? J Clin Oncol 23: 8165-8169
5. Burnet KL et al. (2007) Does active surveillance for men with localized prostate cancer carry psychological morbidity? BJU Int 100: 540-543
6. Choo R et al. (2002) Feasibility study: Watchful waiting for localized low to intermediate grade prostate carcinoma with selective delayed intervention based on prostate specific antigen, histological and/or clinical progression. J Urol 167: 1664-1669
7. Albertsen PC et al. (2005) 20-year outcomes following conservative management of clinically localized prostate cancer. JAMA 293 2095-2101
8. Bill-Axelson A et al. (2005) Radical prostatectomy versus watchful waiting in early prostate cancer. N Engl J Med 352: 1977-1984
9. Parker C et al. (2006) A model of the natural history of screen-detected prostate cancer, and the effect of radical treatment on overall survival. Br J Cancer 94: 1361-1368